PCM
OSCR icon

Prelude Capital Management’s Oscar Health OSCR Stock Holding History

Prelude Capital Management’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-64,000
Closed -$920K – 1491
2025
Q4 		$920K Buy
+64,000
New +$1.11M 0.07% 335
2024
Q4 		– Sell
-57,958
Closed -$1.23M – 1452
2024
Q3 		$1.23M Buy
57,958
+30,167
+109% +$543K 0.07% 328
2024
Q2 		$440K Buy
27,791
+1,163
+4% +$21.4K 0.03% 596
2024
Q1 		$396K Buy
+26,628
New +$365K 0.02% 744
2023
Q4 		– Sell
-26,406
Closed -$147K – 1272
2023
Q3 		$147K Buy
+26,406
New +$185K 0.01% 953
2022
Q2 		– Sell
-13,686
Closed -$136K – 2000
2022
Q1 		$136K Buy
+13,686
New +$102K ﹤0.01% 1348

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prelude Capital Management's OSCR Position: Q1 2026 in Review

Prelude Capital Management sold out of Oscar Health (OSCR) in Q1 2026, closing a stake of 64,000 shares — an estimated $920K sold.

Prelude Capital Management first reported a position in OSCR in Q1 2022 and held it in 6 quarters. The position peaked at $1.23M in Q3 2024. 332 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Prelude Capital Management reported no remaining Oscar Health position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 64,000 Oscar Health shares in Q1 2026, an estimated $920K.
  • Prelude Capital Management first reported a position in Oscar Health in Q1 2022 and held it in 6 quarters.
  • Prelude Capital Management's Oscar Health position peaked at $1.23M in Q3 2024.
  • 332 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.